Dash, Prasanta K.
Gorantla, Santhi
Poluektova, Larisa
Hasan, Mahmudul
Waight, Emiko
Zhang, Chen
Markovic, Milica
Edagwa, Benson
Machhi, Jatin
Olson, Katherine E.
Wang, Xinglong
Mosley, R. Lee
Kevadiya, Bhavesh
Gendelman, Howard E.
Funding for this research was provided by:
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (1R01AI158160-01A1)
Article History
Received: 16 April 2021
Accepted: 22 May 2021
First Online: 5 June 2021
Declarations
:
: Not applicable.
: Not applicable.
: BE and HEG are co-founders of Exavir Therapeutics, Inc, a company formed to developed extended action antiretroviral drug therapies.